Quick Comparison

MelatoninThymosin Beta-4
Half-Life40-60 minutes (oral); injectable forms have shorter half-life1-2 hours
Typical DosageOral (sleep): 0.5-5 mg once, 30-60 minutes before bed (lower doses of 0.5-1 mg are often more effective than higher doses). Extended-release forms available for sleep maintenance. Injectable: 10-20 mg for research protocols. High-dose IV: used in some anti-aging and oncology protocols.Loading: 750 mcg-2 mg subcutaneous two or three times weekly for 2-4 weeks. Maintenance: 750 mcg-2 mg subcutaneous once or twice weekly. Some protocols use higher loading doses for acute injuries.
AdministrationOral (tablet, liquid, sublingual), injectable, or topicalSubcutaneous injection
Research Papers32 papers30 papers
Categories

Mechanism of Action

Melatonin

Melatonin (N-acetyl-5-methoxytryptamine) is synthesized in the pineal gland from serotonin through a two-step pathway: N-acetyltransferase (AANAT) converts serotonin to N-acetylserotonin, and hydroxyindole O-methyltransferase (HIOMT) converts it to melatonin. AANAT activity is under direct control of the suprachiasmatic nucleus (SCN) master circadian clock — it is strongly suppressed by light (via the retinohypothalamic tract) and activated in darkness, creating the characteristic nocturnal melatonin surge that signals nighttime to every cell in the body.

Melatonin acts through two high-affinity G protein-coupled receptors: MT1 (MTNR1A) and MT2 (MTNR1B), both of which are Gi/o-coupled, inhibiting adenylyl cyclase and reducing cAMP when activated. MT1 receptors in the SCN mediate the acute sleep-promoting effect — their activation inhibits the firing rate of SCN neurons, reducing the alerting signal from the master clock and promoting sleepiness. MT2 receptors in the SCN mediate circadian phase-shifting — their activation during the biological evening advances the clock phase (useful for jet lag and delayed sleep phase), while activation during the biological morning delays it. This dual receptor mechanism explains why melatonin both promotes acute sleepiness and shifts circadian timing.

Beyond sleep, melatonin is one of the most potent endogenous antioxidants. It directly scavenges hydroxyl radicals, superoxide anions, hydrogen peroxide, and peroxynitrite through electron donation. Uniquely, melatonin's antioxidant cascade is amplified — its metabolites (cyclic 3-hydroxymelatonin, AFMK, AMK) are themselves antioxidants, so each melatonin molecule can neutralize up to 10 reactive oxygen species in a cascade. Melatonin also upregulates antioxidant enzymes (superoxide dismutase, glutathione peroxidase, catalase) and downregulates pro-oxidant enzymes (nitric oxide synthase, lipoxygenase). In the immune system, MT1 receptors on T helper cells, natural killer cells, and eosinophils modulate immune function — melatonin generally enhances Th1 cellular immunity, increases NK cell activity, and augments antibody responses to vaccination, which has led to interest in melatonin as an immunomodulator in aging and cancer.

Thymosin Beta-4

Thymosin Beta-4 (Tβ4) is a 43-amino-acid peptide and the most abundant member of the beta-thymosin family. Despite its name (derived from its original isolation from thymus tissue), Tβ4 is expressed in virtually every nucleated cell in the body and is particularly concentrated in platelets, wound fluid, and developing tissues. TB-500 is the commercially available active fragment.

The primary molecular function is G-actin sequestration. Tβ4 binds globular actin (G-actin) monomers at a 1:1 stoichiometric ratio through a central actin-binding domain (LKKTET motif), maintaining a large intracellular pool of unpolymerized actin available for rapid mobilization. When cells need to migrate — as during wound healing, inflammation, or development — Tβ4 releases G-actin for polymerization into filamentous actin (F-actin) at the cell's leading edge. This dynamic actin cycling is the fundamental force-generating mechanism for cell migration.

Beyond actin regulation, Tβ4 has extensive signaling functions. It promotes angiogenesis by stimulating endothelial cell migration, tubule formation, and the expression of VEGF and angiopoietin-1. It reduces inflammation by modulating NF-κB signaling, decreasing production of TNF-α, IL-1β, and other pro-inflammatory mediators. In wound healing, Tβ4 upregulates laminin-5 production — a key component of the basement membrane that guides epithelial cell migration during wound re-epithelialization. It activates cardiac progenitor cells and promotes cardiomyocyte survival following ischemic injury, an effect that has generated significant interest for cardiac repair applications.

Tβ4 also promotes stem cell migration and differentiation through activation of the Akt cell survival pathway. It stimulates hair follicle stem cell migration and differentiation, which has been observed as increased hair growth in animal studies. The combination of cell migration, angiogenesis, anti-inflammation, stem cell activation, and extracellular matrix remodeling makes Tβ4 one of the most comprehensive endogenous healing molecules identified.

Risks & Safety

Melatonin

Common

daytime drowsiness, headache, vivid or unusual dreams, mild dizziness, next-morning grogginess at higher doses.

Serious

potential suppression of your body's own melatonin production with long-term use, drug interactions with blood thinners (warfarin) and immunosuppressants.

Rare

depressed mood, sleep-walking, allergic reactions.

Thymosin Beta-4

Common

injection site irritation, headache, nausea, temporary fatigue.

Serious

may promote existing tumors by stimulating new blood vessel formation and cell movement, no long-term data on effects on tissue remodeling.

Rare

allergic reactions, localized infection.

Full Profiles